NDC 67877-474 – Dabigatran Etexilate
Dabigatran Etexilate Mesylate 75 mg/1 · Capsule, Coated Pellets · Oral
Product NDC67877-474
Product details
- Brand name
- Dabigatran Etexilate
- Generic name
- Dabigatran Etexilate
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- Capsule, Coated Pellets
- Route
- Oral
- Marketing category
- ANDA · ANDA208040
- Marketed since
- June 20, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Direct Thrombin Inhibitor
Active ingredients
- Dabigatran Etexilate Mesylate 75 mg/1
Uses, dosage, side effects and warnings for Dabigatran Etexilate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 67877-474-60 | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) | Jun 20, 2022 |
Recalls mentioning this NDC
- D-0129-2025 Dec 18, 2024 · Class II
CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit - D-0130-2025 Dec 18, 2024 · Class II
CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit - D-0533-2023 Apr 5, 2023 · Class II
CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels above the Acceptable Daily Intake Limit. - D-0534-2023 Apr 5, 2023 · Class II
CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels above the Acceptable Daily Intake Limit.
Other Dabigatran Etexilate products
- 50090-7656 Dabigatran Etexilate Mesylate 75 mg/1 · Capsule, Coated Pellets · A-S Medication Solutions
- 50090-7657 Dabigatran Etexilate Mesylate 150 mg/1 · Capsule, Coated Pellets · A-S Medication Solutions
- 62332-634 Dabigatran Etexilate Mesylate 75 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-635 Dabigatran Etexilate Mesylate 110 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-636 Dabigatran Etexilate Mesylate 150 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 46708-636 Dabigatran Etexilate Mesylate 150 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-634 Dabigatran Etexilate Mesylate 75 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-635 Dabigatran Etexilate Mesylate 110 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 60505-4349 Dabigatran Etexilate Mesylate 110 mg/1 · Capsule · Apotex Corp.
- 60505-4347 Dabigatran Etexilate Mesylate 75 mg/1 · Capsule · Apotex Corp.
- 60505-4348 Dabigatran Etexilate Mesylate 150 mg/1 · Capsule · Apotex Corp.
- 67877-475 Dabigatran Etexilate Mesylate 150 mg/1 · Capsule, Coated Pellets · Ascend Laboratories, LLC